Evidence map›Paper›PMID 38982297›Full record

ArticleNature medicine2024

Author Correction: Lisocabtagene maraleucel in follicular lymphoma: the phase 2 TRANSCEND FL study.

Franck Morschhauser, Saurabh Dahiya, M Lia Palomba, Alejandro Martin Garcia-Sancho, Juan Luis Reguera Ortega, John Kuruvilla, Ulrich Jäger, Guillaume Cartron, Koji Izutsu, Martin Dreyling and 23 more

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Nature medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Trial
  2. Review
  3. Review
  4. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

33 authors.

Franck MorschhauserCentre Hospitalier Universitaire de Lille, Groupe de Recherche sur les formes Injectables et les Technologies Associées, Lille, France. franck.morschhauser@chu-lille.fr.ORCID http://orcid.org/0000-0002-3714-9824
Saurabh DahiyaStanford University School of Medicine, Stanford, CA, USA.
M Lia PalombaMemorial Sloan Kettering Cancer Center, New York, NY, USA.ORCID http://orcid.org/0000-0001-5099-9156
Alejandro Martin Garcia-SanchoHospital Universitario de Salamanca, IBSAL, CIBERONC, Centro de Investigación del Cáncer-IBMCC (USAL-CSIC), Salamanca, Spain.
Juan Luis Reguera OrtegaHospital Virgen del Rocío, Instituto de Biomedicina de la Universidad de Sevilla, Seville, Spain.
John KuruvillaPrincess Margaret Cancer Centre, Toronto, Ontario, Canada.
Ulrich JägerMedical University of Vienna, Vienna, Austria.ORCID http://orcid.org/0000-0001-9826-1062
Guillaume CartronMontpellier University Hospital Center, UMR CNRS 5535, Montpellier, France.
Koji IzutsuNational Cancer Center Hospital, Tokyo, Japan.ORCID http://orcid.org/0000-0001-9129-8057
Martin DreylingLMU University Hospital, München, Germany.
Brad KahlWashington University School of Medicine in St. Louis, St. Louis, MO, USA.
Hervé GhesquieresHôpital Lyon Sud, Lyon, France.
Kirit ArdeshnaUniversity College London Hospitals Biomedical Research Centre, London, UK.
Hideki GotoHokkaido University Hospital, Sapporo, Japan.
Anna Maria BarbuiAzienda Socio Sanitaria Territoriale Papa Giovanni XXIII, Bergamo, Italy.
Jeremy S AbramsonMassachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, USA.ORCID http://orcid.org/0000-0001-8467-9257
Peter BorchmannUniversität zu Köln, Köln, Germany.
Isabelle FleuryHôpital Maisonneuve - Rosemont, Montreal, Quebec, Canada.
Stephan MielkeKarolinska Institutet and University Hospital, Karolinska Comprehensive Cancer Center, Karolinska ATMP Center, Stockholm, Sweden.
Alan SkarbnikNovant Health Cancer Institute, Charlotte, NC, USA.
Sven de VosUCLA Santa Monica Medical Centre, Santa Monica, CA, USA.
Manali KamdarUniversity of Colorado Cancer Center, Aurora, CO, USA.
Reem KarmaliNorthwestern University Feinberg School of Medicine, Robert H. Lurie Comprehensive Cancer Center, Chicago, IL, USA.ORCID http://orcid.org/0000-0003-0984-4376
Andreas ViardotDepartment of Internal Medicine III, University Hospital, Ulm, Germany.
Thalia FaraziBristol Myers Squibb, Brisbane, CA, USA.
Omotayo FasanBristol Myers Squibb, Princeton, NJ, USA.
James LympBristol Myers Squibb, Seattle, WA, USA.
Min VedalBristol Myers Squibb, Seattle, WA, USA.
Rina NishiiBristol Myers Squibb, Princeton, NJ, USA.
Ariel AvilionBristol Myers Squibb, Seattle, WA, USA.
Jessica PapugaBristol Myers Squibb, Boudry, Switzerland.
Jinender KumarBristol Myers Squibb, Princeton, NJ, USA.ORCID http://orcid.org/0000-0001-8490-6317
Loretta J NastoupilThe University of Texas MD Anderson Cancer Center, Houston, TX, USA.ORCID http://orcid.org/0000-0001-6071-8610

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID38982297
PMCPMC11333276

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.